FUROSEMIDE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9822 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of one package of Furosemide Injection, 10 mL vials at 10 mg/mL, identified by NSN 6505015250326 and NDC 63323-0280-10, with a total contract value of $60.95. The award was issued on July 14, 2026, with delivery required FOB destination to the USNS LOYAL T (FPO AP 96671), where the government assumes responsibility for inspection and acceptance upon receipt. The contractor is responsible for all transportation costs and must ensure packaging and marking comply with standard military logistics practices, including use of the Transportation Control Number N218686195S591, CAGE 57KZ6, and NSN on all labels. Invoicing must be submitted manually to the Defense Finance and Accounting Service in Columbus, Ohio, adhering to DFARS 252.232-7003, which mandates payment via electronic funds transfer and specifies remittance details. The awardee is certified as a small business, a small disadvantaged business, and a women-owned small business, triggering compliance obligations under FAR and DFARS reporting requirements. No options, variations, or additional line items are present, and the contract is structured as a firm fixed price delivery order with zero variance permitted. The contracting officer is Lisa Quinn, with Jayne Do as the administrative contact, and no COR or COTR has been designated. While specific technical specifications, quality standards, or packaging methods are not detailed in the order, compliance with MIL-STD-129 and MIL-STD-2073-1 is implied by DLA standard practice. The acquisition was conducted under NAICS 424210 and processed through the DIBBS system without solicitation or evaluation factors publicly disclosed, indicating a streamlined procurement likely under simplified acquisition procedures.